Cadila Healthcare inches up on the bourses

08 Apr 2019 Evaluate

Cadila Healthcare is currently trading at Rs. 346.00, up by 1.25 points or 0.36% from its previous closing of Rs. 344.75 on the BSE.

The scrip opened at Rs. 347.00 and has touched a high and low of Rs. 350.05 and Rs. 344.85 respectively. So far 12129 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 432.40 on 10-Sep-2018 and a 52 week low of Rs. 306.35 on 15-Feb-2019.

Last one week high and low of the scrip stood at Rs. 352.30 and Rs. 337.30 respectively. The current market cap of the company is Rs. 35406.14 crore.

The promoters holding in the company stood at 74.79%, while Institutions and Non-Institutions held 17.33% and 7.88% respectively.

Zydus Cadila has received the tentative approval from the United States Food & Drug Administration (USFDA) to market Lacosamide Tablets (US RLD -Vimpat) in the strengths of 50 mg, 100 mg, 150 mg and 200 mg. Lacosamide is an anticonvulsant or antiepileptic drug, used to prevent and control seizures. It works by reducing the spread of seizure activity in the brain. The drug will be manufactured at the group’s formulations manufacturing facility at Moraiya, Ahmedabad in the state of Gujarat.

The group now has 261 approvals and has so far filed over 350 ANDA’s since the commencement of the filing process in FY 2003-04.

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.

Zydus Lifesciences Share Price

916.25 -2.10 (-0.23%)
18-Dec-2025 10:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1753.85
Dr. Reddys Lab 1272.55
Cipla 1500.30
Zydus Lifesciences 916.25
Lupin 2111.25
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×